SPARC neonatal seizures drug Phenobarbital gets Orphan Drug Designation from USFDA Farhat Nasim5 Oct 2019 12:00 PM ISTOrphan Drug Designation will grant seven years of US market exclusivity upon approval of Phenobarbital for the treatment of patients with neonatal...
Lupin unveils generic version of CellCept in US Farhat Nasim5 Oct 2019 9:30 AM ISTLupin Ltd's Mycophenolate Mofetil Capsules USP, 250 mg, is the generic version of Roche’s CellCept. Mumbai: Pharma major Lupin Limited (Lupin)...
JnJ submits New Drug Application to USFDA for Spravato Medical Dialogues Bureau5 Oct 2019 9:00 AM ISTNew Delhi: The Janssen Pharmaceutical Companies of Johnson & Johnson(JnJ) recently announced the submission of a supplemental New Drug Application...
AstraZeneca auto-injector pen Fasenra for asthma treatment gets USFDA green light Farhat Nasim4 Oct 2019 1:42 PM ISTFasenra self-administration and the Fasenra Pen are already approved in the European Union and the drug is part of AstraZeneca’s newer class of...
Gilead Descovy wins USFDA approval for preventing sexually acquired HIV infection Medical Dialogues Bureau4 Oct 2019 12:46 PM ISTDescovy, a combination drug, was approved in 2016 to treat people already infected with HIV. It contains a newer formulation of a drug used in Gilead...
Alembic JV Aleor Derma gets USFDA nod for therapeutic equivalent of Clobex Spray Farhat Nasim4 Oct 2019 12:40 PM ISTClobetasol Propionate Spray, 0.05% is indicated for the treatment of moderate to severe plaque psoriasis affecting up to 20% body surface area (BSA)...
Chennai-based Shield Healthcare acquires Brio Bliss Life Science, Nutri Synapzz Medical Dialogues Bureau4 Oct 2019 9:15 AM ISTShield Healthcare said pharmaceuticals and healthcare-focused private equity firm, Fulcrum Venture would also hold significant stake post the...
Bristol-Myers CEO says Japan restrictive drug price policies risk diverting investment Medical Dialogues Bureau4 Oct 2019 9:00 AM ISTJapan is also a major centre for pharma research, producing drugs such as Opdivo, a blockbuster cancer drug licensed globally by Bristol-Myers.TOKYO:...
Dr Lal PathLabs to acquire 70 percent stake in Amins Pathology Referral Laboratory Medical Dialogues Bureau3 Oct 2019 4:34 PM ISTNew Delhi: Diagnostic chain Dr Lal PathLabs said the board of its arm PathLabs Unifiers has approved acquisition of 70 per cent stake in Amins...
Roche presents positive Phase III results for Tecentriq Medical Dialogues Bureau3 Oct 2019 4:17 PM ISTRoche has recently presented positive results from the Phase III IMvigor130 study evaluating Tecentriq® (atezolizumab) plus platinum-based...
Sreeji Gopinathan joins Lupin as Chief Information Officer Medical Dialogues Bureau3 Oct 2019 4:03 PM ISTMumbai, October 03, 2019: Pharma major Lupin Limited announced today the appointment of Sreeji Gopinathan as Chief Information Officer (CIO). He will...
Biocon, Mylan launch insulin biosimilar Semglee in Australia Medical Dialogues Bureau3 Oct 2019 3:51 PM ISTNew Delhi: Biotechnology major Biocon and pharmaceutical company Mylan N V on Thursday announced the launch of their insulin biosimilar Semglee,...
